about
Neuroprotection mediated by inhibition of calpain during acute viral encephalitisWeek 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patientsA review of drug-drug interactions in older HIV-infected patients.CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safety of pharmacoenhancers for HIV therapy.
@en
type
label
Safety of pharmacoenhancers for HIV therapy.
@en
prefLabel
Safety of pharmacoenhancers for HIV therapy.
@en
P2860
P356
P1476
Safety of pharmacoenhancers for HIV therapy.
@en
P2093
Annette Haberl
Nils von Hentig
P2860
P304
P356
10.1586/ECP.12.45
P407
P577
2012-09-01T00:00:00Z